AB0637 Iloprost (ILO) in Systemic Sclerosis (SSC): The Safety Experience of Two Italian Centres

S. Guiducci; S. Bellando-Randone; C. Bruni; D. Giuggioli; M. Colaci; F. Lumetti; G. Lepri; G. Fiori; F. Bartoli; C. Ferri; M. Matucci-Cerinic

doi:10.1136/annrheumdis-2016-eular.6089

Article info

Abstracts Accepted for Publication

Scleroderma, myositis and related syndromes

AB0637 Iloprost (ILO) in Systemic Sclerosis (SSC): The Safety Experience of Two Italian Centres

Authors

S. Guiducci 1Department of experimental and clinical medicine, division of Rheumatology, University of Firenze, Firenze PubMed articles Google scholar articles
S. Bellando-Randone 1Department of experimental and clinical medicine, division of Rheumatology, University of Firenze, Firenze PubMed articles Google scholar articles
C. Bruni 1Department of experimental and clinical medicine, division of Rheumatology, University of Firenze, Firenze PubMed articles Google scholar articles
D. Giuggioli 2Rheumatology Unit, University of Modena and Reggio Emilia, Modena, Italy PubMed articles Google scholar articles
M. Colaci 2Rheumatology Unit, University of Modena and Reggio Emilia, Modena, Italy PubMed articles Google scholar articles
F. Lumetti 2Rheumatology Unit, University of Modena and Reggio Emilia, Modena, Italy PubMed articles Google scholar articles
G. Lepri 1Department of experimental and clinical medicine, division of Rheumatology, University of Firenze, Firenze PubMed articles Google scholar articles
G. Fiori 1Department of experimental and clinical medicine, division of Rheumatology, University of Firenze, Firenze PubMed articles Google scholar articles
F. Bartoli 1Department of experimental and clinical medicine, division of Rheumatology, University of Firenze, Firenze PubMed articles Google scholar articles
C. Ferri 2Rheumatology Unit, University of Modena and Reggio Emilia, Modena, Italy PubMed articles Google scholar articles
M. Matucci-Cerinic 1Department of experimental and clinical medicine, division of Rheumatology, University of Firenze, Firenze PubMed articles Google scholar articles

Citation

Guiducci S, Bellando-Randone S, Bruni C, et al

AB0637 Iloprost (ILO) in Systemic Sclerosis (SSC): The Safety Experience of Two Italian Centres

Annals of the Rheumatic Diseases 2016;75:1122.

Publication history

First published July 15, 2016.

Online issue publication

July 15, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password